Aster Capital Management (Difc) LTD Silverback Therapeutics, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 608 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
608Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SBTX
# of Institutions
178Shares Held
70.2MCall Options Held
218KPut Options Held
329K-
Ra Capital Management, L.P. Boston, MA10.9MShares$00.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY10.5MShares$00.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.29MShares$00.0% of portfolio
-
Black Rock Inc. New York, NY4.08MShares$00.0% of portfolio
-
Sr One Capital Management, LP4.01MShares$00.0% of portfolio
About Silverback Therapeutics, Inc.
- Ticker SBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,473,800
- Description
- Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...